Document de presse | 2017.03.31
Scientists at the Institut Pasteur and their partners in the international TBVAC2020 consortium have just developed a tuberculosis vaccine candidate derived from conventional BCG. This vaccine candidate has higher efficacy, due to a heterologous system of protein secretion that increases the quality and magnitude of the immune responses to virulent strains of Mycobacterium tuberculosis – the...
News | 2017.06.22
RNA viruses, like influenza viruses, have broad genetic variability, which gives them a high adaptive potential. As part of the fight against RNA viruses, scientists at the Institut Pasteur – evolutionary virologists – decided to alter their future. Along with colleagues from Lund University (Sweden), they succeeded in altering the genomes of an enterovirus and an influenza virus, thereby...
Document de presse | 2023.11.14
A team of scientists from the Institut Pasteur has used the database of the National Reference Center for Meningococci to trace the evolution of invasive meningococcal disease cases in France between 2015 and 2022, revealing an unprecedented resurgence in the disease after the easing of control measures imposed during the COVID-19 epidemic. Recently reported cases have mainly been caused by...
Article | 2024.04.30
Physicist and biologist Charles Chamberland was one of Louis Pasteur’s earliest associates. Associated with much of his tutor’s work, he was also a great inventor, designing an autoclave and a water filter, which are both named after him.
News | 2025.04.30
Did you know that certain viruses can cause cancer? Which viruses and which cancers are involved? How do we explain the link between viruses and cancer? Follow the MOOC “Viruses and Human Cancers” to find out more.
News | 2013.10.09
A study carried out by teams from the Institut Pasteur, the Institut Cochin (Inserm, CNRS, Paris Descartes University), and the Wellcome Trust Centre for Molecular Parasitology at the University of Glasgow, may very well redefine current approaches to malaria and toxoplasmosis research in terms of treatment development. Their research which focuses on the role played by the protein AMA1 (present...
News | 2018.01.19
The Swiss Tropical and Public Health Institute, together with European and African collaborators (including the Institut Pasteur in Paris), carried out a mass dog vaccination in Chad and determined its effect on human rabies exposure. The study employed a bio-mathematical method for estimating the transmission dynamics of rabies. The researchers conclude that with political will and the necessary...
News | 2019.09.19
The BTP PLUS Foundation, a joint foundation representing the construction sector, signed a sponsorship agreement with the Institut Pasteur in the spring to fund a research project led by Frédéric Tangy, an Institut Pasteur scientist. The aim of the project is to fight mesothelioma, an asbestos-related cancer that particularly affects people working in the construction sector.The BTP PLUS...
News | 2022.05.16
The Institut Pasteur and Moderna have signed a Master Material Transfer Agreement (MMTA) to enable researchers of the Institut Pasteur to have access to Moderna's preclinical manufacturing capabilities and its research and development expertise. The objective is to jointly explore the possibility of mRNA to tackle the world's greatest global public health threats. Institut Pasteur...
Report | 2022.04.06
This year marks the bicentenary of Louis Pasteur's birth. His reputation speaks for itself, with streets and schools named after him in France and across the world. His immense legacy can even be seen in our homes, in the "pasteurized" products derived from one of his discoveries. And it was Pasteur who laid the scientific foundations for the principles of hygiene, which took on such importance...